← Back to Search

UR-GOAL Communication Tool for Acute Myeloid Leukemia (UR-GOAL 2 Trial)

N/A
Recruiting
Led By Kah Poh Loh
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who are English-speaking
Patients with newly diagnosed AML or being worked up for possible AML
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1-4 weeks after treatment initiation
Awards & highlights

UR-GOAL 2 Trial Summary

This trial will test a new tool to help patients and their oncologists communicate better and make shared decisions.

Who is the study for?
This trial is for people aged 60 or older who have been newly diagnosed with Acute Myeloid Leukemia (AML) or are being evaluated for it. They must be able to make their own medical decisions and speak English. Caregivers can also join if they support the patient in health matters, are over 21, and speak English. Oncologists treating these patients can participate too.Check my eligibility
What is being tested?
The UR-GOAL tool is being tested against usual care to see if it improves how doctors and older AML patients talk about treatment options together. The study will involve 100 participants to check how well the tool works in real conversations.See study design
What are the potential side effects?
Since this trial focuses on a communication tool rather than a medication, there aren't typical drug side effects involved. However, discussing sensitive health information could potentially cause emotional discomfort.

UR-GOAL 2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English.
Select...
I have been recently diagnosed with AML or am being tested for it.
Select...
I am 60 years old or older.

UR-GOAL 2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1-4 weeks after treatment initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1-4 weeks after treatment initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Shared Decision Making
Secondary outcome measures
Patient-Centered Communication in Cancer Care (PCC-Ca-36)

UR-GOAL 2 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: UR-GOALExperimental Treatment1 Intervention
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
Group II: Usual careActive Control1 Intervention
Usual care

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
834 Previous Clinical Trials
518,192 Total Patients Enrolled
Kah Poh LohPrincipal InvestigatorUniversity of Rochester
5 Previous Clinical Trials
210 Total Patients Enrolled

Media Library

UR-GOAL Clinical Trial Eligibility Overview. Trial Name: NCT05335369 — N/A
Acute Myeloid Leukemia Research Study Groups: UR-GOAL, Usual care
Acute Myeloid Leukemia Clinical Trial 2023: UR-GOAL Highlights & Side Effects. Trial Name: NCT05335369 — N/A
UR-GOAL 2023 Treatment Timeline for Medical Study. Trial Name: NCT05335369 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applications being accepted for this trial at the present time?

"According to clinicaltrials.gov, this research effort is actively enrolling participants. It was initially made public on June 17th 2022 and the details were recently updated on the 21st of that month."

Answered by AI

How many enrollees are participating in this trial?

"Affirmative. Clinicaltrials.gov confirms the enrollment of patients in this medical research initiated on June 17th 2022 and updated four days later. The study seeks out 100 participants from a single site."

Answered by AI
~42 spots leftby Jun 2025